These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 27472820)

  • 1. Standardised surveillance of Clostridium difficile infection in European acute care hospitals: a pilot study, 2013.
    van Dorp SM; Kinross P; Gastmeier P; Behnke M; Kola A; Delmée M; Pavelkovich A; Mentula S; Barbut F; Hajdu A; Ingebretsen A; Pituch H; Macovei IS; Jovanović M; Wiuff C; Schmid D; Olsen KE; Wilcox MH; Suetens C; Kuijper EJ;
    Euro Surveill; 2016 Jul; 21(29):. PubMed ID: 27472820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survey of diagnostic and typing capacity for Clostridium difficile infection in Europe, 2011 and 2014.
    van Dorp SM; Notermans DW; Alblas J; Gastmeier P; Mentula S; Nagy E; Spigaglia P; Ivanova K; Fitzpatrick F; Barbut F; Morris T; Wilcox MH; Kinross P; Suetens C; Kuijper EJ;
    Euro Surveill; 2016 Jul; 21(29):. PubMed ID: 27469624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survey of Clostridium difficile infection surveillance systems in Europe, 2011.
    Kola A; Wiuff C; Akerlund T; van Benthem BH; Coignard B; Lyytikäinen O; Weitzel-Kage D; Suetens C; Wilcox MH; Kuijper EJ; Gastmeier P;
    Euro Surveill; 2016 Jul; 21(29):. PubMed ID: 27469420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hospital-based Clostridium difficile infection surveillance reveals high proportions of PCR ribotypes 027 and 176 in different areas of Poland, 2011 to 2013.
    Pituch H; Obuch-Woszczatyński P; Lachowicz D; Wultańska D; Karpiński P; Młynarczyk G; van Dorp SM; Kuijper EJ;
    Euro Surveill; 2015; 20(38):. PubMed ID: 26536049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diversity of Clostridium difficile PCR ribotypes in Europe: results from the European, multicentre, prospective, biannual, point-prevalence study of Clostridium difficile infection in hospitalised patients with diarrhoea (EUCLID), 2012 and 2013.
    Davies KA; Ashwin H; Longshaw CM; Burns DA; Davis GL; Wilcox MH;
    Euro Surveill; 2016 Jul; 21(29):. PubMed ID: 27470194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How to: Surveillance of Clostridium difficile infections.
    Krutova M; Kinross P; Barbut F; Hajdu A; Wilcox MH; Kuijper EJ;
    Clin Microbiol Infect; 2018 May; 24(5):469-475. PubMed ID: 29274463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variability in testing policies and impact on reported Clostridium difficile infection rates: results from the pilot Longitudinal European Clostridium difficile Infection Diagnosis surveillance study (LuCID).
    Davies K; Davis G; Barbut F; Eckert C; Petrosillo N; Wilcox MH
    Eur J Clin Microbiol Infect Dis; 2016 Dec; 35(12):1949-1956. PubMed ID: 27590621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced surveillance of Clostridium difficile infection occurring outside hospital, England, 2011 to 2013.
    Fawley WN; Davies KA; Morris T; Parnell P; Howe R; Wilcox MH;
    Euro Surveill; 2016 Jul; 21(29):. PubMed ID: 27487436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction in Clostridium difficile infections in Finland, 2008-2010.
    Kanerva M; Mentula S; Virolainen-Julkunen A; Kärki T; Möttönen T; Lyytikäinen O;
    J Hosp Infect; 2013 Feb; 83(2):127-31. PubMed ID: 23201398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changing epidemiology of Clostridium difficile infection following the introduction of a national ribotyping-based surveillance scheme in England.
    Wilcox MH; Shetty N; Fawley WN; Shemko M; Coen P; Birtles A; Cairns M; Curran MD; Dodgson KJ; Green SM; Hardy KJ; Hawkey PM; Magee JG; Sails AD; Wren MW
    Clin Infect Dis; 2012 Oct; 55(8):1056-63. PubMed ID: 22784871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clostridium difficile PCR ribotypes 001 and 176 - the common denominator of C. difficile infection epidemiology in the Czech Republic, 2014.
    Krutova M; Matejkova J; Kuijper EJ; Drevinek P; Nyc O;
    Euro Surveill; 2016 Jul; 21(29):. PubMed ID: 27484171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole-genome sequencing improves discrimination of relapse from reinfection and identifies transmission events among patients with recurrent Clostridium difficile infections.
    Mac Aogáin M; Moloney G; Kilkenny S; Kelleher M; Kelleghan M; Boyle B; Rogers TR
    J Hosp Infect; 2015 Jun; 90(2):108-16. PubMed ID: 25935700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pilot study in Serbia by European Clostridium difficile Infection Surveillance Network.
    Jovanović M; van Dorp SM; Drakulović M; Papić D; Pavić S; Jovanović S; Lešić A; Korać M; Milošević I; Kuijper EJ
    Acta Microbiol Immunol Hung; 2019 Dec; 67(1):42-48. PubMed ID: 31813261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and Microbiological Characteristics of Clostridium difficile Infection Among Hospitalized Children in the Netherlands.
    van Dorp SM; Smajlović E; Knetsch CW; Notermans DW; de Greeff SC; Kuijper EJ
    Clin Infect Dis; 2017 Jan; 64(2):192-198. PubMed ID: 27986664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First clinical and microbiological characterization of Clostridium difficile infection in a Croatian University Hospital.
    Novak A; Spigaglia P; Barbanti F; Goic-Barisic I; Tonkic M
    Anaerobe; 2014 Dec; 30():18-23. PubMed ID: 25079669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Underdiagnosis of Clostridium difficile across Europe: the European, multicentre, prospective, biannual, point-prevalence study of Clostridium difficile infection in hospitalised patients with diarrhoea (EUCLID).
    Davies KA; Longshaw CM; Davis GL; Bouza E; Barbut F; Barna Z; Delmée M; Fitzpatrick F; Ivanova K; Kuijper E; Macovei IS; Mentula S; Mastrantonio P; von Müller L; Oleastro M; Petinaki E; Pituch H; Norén T; Nováková E; Nyč O; Rupnik M; Schmid D; Wilcox MH
    Lancet Infect Dis; 2014 Dec; 14(12):1208-19. PubMed ID: 25455988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occurrence of Clostridium difficile PCR-ribotype 027 and it's closely related PCR-ribotype 176 in hospitals in Poland in 2008-2010.
    Obuch-Woszczatyński P; Lachowicz D; Schneider A; Mól A; Pawłowska J; Ożdżeńska-Milke E; Pruszczyk P; Wultańska D; Młynarczyk G; Harmanus C; Kuijper EJ; van Belkum A; Pituch H
    Anaerobe; 2014 Aug; 28():13-7. PubMed ID: 24799338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical features and characteristics of Clostridium difficile PCR-ribotype 176 infection: results from a 1-year university hospital internal ward study.
    Drabek J; Nyc O; Krutova M; Stovicek J; Matejkova J; Keil R
    Ann Clin Microbiol Antimicrob; 2015 Dec; 14():55. PubMed ID: 26698842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective study of community-associated Clostridium difficile infections: the role of antibiotics and co-infections.
    Taori SK; Wroe A; Hardie A; Gibb AP; Poxton IR
    J Infect; 2014 Aug; 69(2):134-44. PubMed ID: 24780765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What do we know about the diagnostics, treatment and epidemiology of Clostridioides (Clostridium) difficile infection in Europe?
    Nagy E
    J Infect Chemother; 2018 Mar; 24(3):164-170. PubMed ID: 29289484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.